INCYTE Exec Sells $535k in Stock via Pre-Arranged 10b5-1 Plan
INCYTE CORP
Subscribe to track INCY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
INCYTE Exec Sells $535k in Stock via Pre-Arranged 10b5-1 Plan
Company: INCYTE CORP (INCY) Form: 4 | Filed: 2025-11-07 Significance: Low
Insider: Stein Steven H Title: EVP & Chief Medical Officer | Relationship: Officer
Transaction: • Type: Sale (following option exercise) • Shares: 5,233 • Price: $102.20 • Value: $534,813 • Owned After: 102,886
Key Insight: This is a routine, low-value sale conducted under a pre-scheduled 10b5-1 trading plan. The transaction represents a negligible percentage of the company's market cap and is likely for personal financial management rather than a change in outlook.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: INCYTE CORP (INCY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Incyte conducted a minor, pre-planned sale of stock valued at approximately $535k after exercising options, representing an insignificant fraction of the company's market capitalization.
- Market Impact: The transaction is unlikely to have any market impact due to its small size and execution under a 10b5-1 plan.
Company Information
| Field | Value |
|---|---|
| Company | INCYTE CORP |
| Ticker Symbol | INCY |
| CIK | 0000879169 |
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
Insider Information
| Field | Value |
|---|---|
| Name | Stein Steven H |
| CIK | 0001673776 |
| Title/Position | EVP & Chief Medical Officer |
| Relationship | Officer |
Transaction Details
This filing reports the exercise of stock options and the subsequent sale of the acquired shares. The most relevant market event is the sale.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-05 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 5,233 |
| Price Per Share | $102.20 |
| Total Value | $534,812.60 |
| Shares Owned After | 102,886 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $534,812.60 |
| % of Market Cap | 0.0026% |
| Shares Transacted | 5,233 |
| % of Shares Outstanding | 0.0027% |
| Post-Transaction Ownership | 102,886 shares (0.053% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $20.75 billion, this $535k transaction is financially immaterial.
- Transaction Significance: The sale represents a negligible percentage of both market cap and shares outstanding, falling far below any threshold for significance. The insider sold less than 5% of their direct holdings.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is too small to influence the stock price. Furthermore, its execution under a 10b5-1 plan, established in advance, strips it of any predictive value regarding the insider's current sentiment.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is a tiny fraction of typical daily trading volume for a large-cap stock like INCY.
- Sentiment Indicator: Neutral. This is a routine 'sell-to-cover' transaction associated with option exercises, common for executive compensation.
Additional Context
Transaction Notes
- Special Circumstances: The filing confirms the transaction was made pursuant to a Rule 10b5-1 trading plan. This indicates the sale was pre-scheduled and not based on any immediate, non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
